These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

475 related items for PubMed ID: 27935537

  • 1. Predictors of Residual Renal Function Decline in Peritoneal Dialysis Patients: The balANZ Trial.
    Htay H, Cho Y, Pascoe EM, Darssan D, Hawley C, Johnson DW, balANZ trial investigators.
    Perit Dial Int; 2017; 37(3):283-289. PubMed ID: 27935537
    [Abstract] [Full Text] [Related]

  • 2. A combination of biocompatible peritoneal dialysis solutions and residual renal function, peritoneal transport, and inflammation markers: a randomized clinical trial.
    Lui SL, Yung S, Yim A, Wong KM, Tong KL, Wong KS, Li CS, Au TC, Lo WK, Ho YW, Ng F, Tang C, Chan TM.
    Am J Kidney Dis; 2012 Dec; 60(6):966-75. PubMed ID: 22835900
    [Abstract] [Full Text] [Related]

  • 3. The Trio Trial - A Randomized Controlled Clinical Trial Evaluating the Effect of a Biocompatible Peritoneal Dialysis Solution on Residual Renal Function.
    Sikaneta T, Wu G, Abdolell M, Ng A, Mahdavi S, Svendrovski A, Tu T, Mercer T, Tong M, Oreopoulos D, Tam P.
    Perit Dial Int; 2012 Dec; 36(5):526-32. PubMed ID: 27282852
    [Abstract] [Full Text] [Related]

  • 4. Biocompatible dialysis fluids for peritoneal dialysis.
    Htay H, Johnson DW, Wiggins KJ, Badve SV, Craig JC, Strippoli GF, Cho Y.
    Cochrane Database Syst Rev; 2018 Oct 26; 10(10):CD007554. PubMed ID: 30362116
    [Abstract] [Full Text] [Related]

  • 5. Risk Factors for Decline of Residual Renal Function in Children Treated With Peritoneal Dialysis.
    Roszkowska-Blaim M, Skrzypczyk P.
    Perit Dial Int; 2018 Oct 26; 36(6):669-675. PubMed ID: 27605680
    [Abstract] [Full Text] [Related]

  • 6. Predictors of decline of residual renal function in new peritoneal dialysis patients.
    Johnson DW, Mudge DW, Sturtevant JM, Hawley CM, Campbell SB, Isbel NM, Hollett P.
    Perit Dial Int; 2003 Oct 26; 23(3):276-83. PubMed ID: 12938830
    [Abstract] [Full Text] [Related]

  • 7. Utility of Urinary Biomarkers in Predicting Loss of Residual Renal Function: The balANZ Trial.
    Cho Y, Johnson DW, Vesey DA, Hawley CM, Clarke M, Topley N, balANZ Trial Investigators.
    Perit Dial Int; 2015 Oct 26; 35(2):159-71. PubMed ID: 24711637
    [Abstract] [Full Text] [Related]

  • 8. Effect of neutral pH and low-glucose degradation product-containing peritoneal dialysis solution on residual renal function in peritoneal dialysis patients: a meta-analysis.
    Wang J, Zhu N, Yuan W.
    Nephron; 2015 Oct 26; 129(3):155-63. PubMed ID: 25765060
    [Abstract] [Full Text] [Related]

  • 9. Association of Incremental peritoneal dialysis with residual kidney function decline in patients on peritoneal dialysis: The balANZ trial.
    Hayat A, Cho Y, Hawley CM, Htay H, Krishnasamy R, Pascoe E, Teitelbaum I, Varnfield M, Johnson DW.
    Perit Dial Int; 2023 Sep 26; 43(5):374-382. PubMed ID: 37259236
    [Abstract] [Full Text] [Related]

  • 10. A Fast Decline of Residual Renal Function in the First Year is a Predictor for Early Withdrawal from Peritoneal Dialysis in Non-Diabetic Patients.
    Wang J, Xie X, Yan X, Yang X, Zhang X, Chen J, Han F.
    Kidney Blood Press Res; 2019 Sep 26; 44(1):12-21. PubMed ID: 30808853
    [Abstract] [Full Text] [Related]

  • 11. Association between inflammation and changes in residual renal function and peritoneal transport rate during the first year of dialysis.
    Chung SH, Heimbürger O, Stenvinkel P, Bergström J, Lindholm B.
    Nephrol Dial Transplant; 2001 Nov 26; 16(11):2240-5. PubMed ID: 11682675
    [Abstract] [Full Text] [Related]

  • 12. Rationale and design of the balANZ trial: a randomised controlled trial of low GDP, neutral pH versus standard peritoneal dialysis solution for the preservation of residual renal function.
    Johnson DW, Clarke M, Wilson V, Woods F, Brown FG.
    BMC Nephrol; 2010 Sep 16; 11():25. PubMed ID: 20843375
    [Abstract] [Full Text] [Related]

  • 13. Could solutions low in glucose degradation products preserve residual renal function in incident peritoneal dialysis patients? A 1-year multicenter prospective randomized controlled trial (Balnet Study).
    Kim SG, Kim S, Hwang YH, Kim K, Oh JE, Chung W, Oh KH, Kim HJ, Ahn C, Korean Balnet Study Group.
    Perit Dial Int; 2008 Jun 16; 28 Suppl 3():S117-22. PubMed ID: 18552239
    [Abstract] [Full Text] [Related]

  • 14. Risk factors for loss of residual renal function in children with end-stage renal disease undergoing automatic peritoneal dialysis.
    Shen Q, Fang X, Zhai Y, Rao J, Chen J, Miao Q, Gong Y, Yu M, Zhou Q, Xu H.
    Perit Dial Int; 2020 Jul 16; 40(4):368-376. PubMed ID: 32063214
    [Abstract] [Full Text] [Related]

  • 15. Changes in echocardiographic parameters according to the rate of residual renal function decline in incident peritoneal dialysis patients.
    Koo HM, Doh FM, Kim CH, Lee MJ, Kim EJ, Han JH, Han JS, Ryu DR, Oh HJ, Park JT, Han SH, Yoo TH, Kang SW.
    Medicine (Baltimore); 2015 Feb 16; 94(7):e427. PubMed ID: 25700308
    [Abstract] [Full Text] [Related]

  • 16. Association between residual renal function, inflammation and patient survival in new peritoneal dialysis patients.
    Chung SH, Heimbürger O, Stenvinkel P, Qureshi AR, Lindholm B.
    Nephrol Dial Transplant; 2003 Mar 16; 18(3):590-7. PubMed ID: 12584284
    [Abstract] [Full Text] [Related]

  • 17. Benefits of biocompatible PD fluid for preservation of residual renal function in incident CAPD patients: a 1-year study.
    Kim S, Oh J, Kim S, Chung W, Ahn C, Kim SG, Oh KH.
    Nephrol Dial Transplant; 2009 Sep 16; 24(9):2899-908. PubMed ID: 19258384
    [Abstract] [Full Text] [Related]

  • 18. Peritoneal dialysis and preservation of residual renal function.
    Tam P.
    Perit Dial Int; 2009 Feb 16; 29 Suppl 2():S108-10. PubMed ID: 19270196
    [Abstract] [Full Text] [Related]

  • 19. The effect of low glucose degradation product, neutral pH versus standard peritoneal dialysis solutions on peritoneal membrane function: the balANZ trial.
    Johnson DW, Brown FG, Clarke M, Boudville N, Elias TJ, Foo MW, Jones B, Kulkarni H, Langham R, Ranganathan D, Schollum J, Suranyi MG, Tan SH, Voss D, balANZ Trial Investigators.
    Nephrol Dial Transplant; 2012 Dec 16; 27(12):4445-53. PubMed ID: 22859794
    [Abstract] [Full Text] [Related]

  • 20. Rate of decline of residual renal function in patients on continuous peritoneal dialysis and factors affecting it.
    Singhal MK, Bhaskaran S, Vidgen E, Bargman JM, Vas SI, Oreopoulos DG.
    Perit Dial Int; 2000 Dec 16; 20(4):429-38. PubMed ID: 11007375
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.